James Bauersmith
Direktor/Vorstandsmitglied bei LANNETT COMPANY, INC.
Profil
James is an experienced healthcare executive with over 20 years of experience across a variety of healthcare segments.
He joined UPMC Enterprises in August of 2021 as Vice President of Translational Sciences.
Before joining Enterprises, James was the Chief Strategic Officer and General Counsel of ByHeart, Inc., an infant formula company, where he led the company’s FDA strategy, managed all of their legal affairs and led the acquisition and set-up of the company’s manufacturing facility.
Prior to his role at ByHeart, James worked in the pharmaceutical sector for over 15 years where he held a variety of leadership positions at Fresenius Kabi, where he was the SVP overseeing the company’s portfolio and marketing strategy unit, and Amneal Pharmaceuticals where he oversaw the corporate development and procurement groups and was part of the executive management team.
Before his tenure at Fresenius and Amneal, James spent 10 years practicing law, first as an attorney in New York with Haug Partners and then as in-house counsel at Teva Pharmaceuticals where he managed the company’s Hatch Waxman Patent litigations.
He earned a B.S.
from the University of Notre Dame, a J.D.
from the Pennsylvania State University School of Law, and an M.S.
of Bioscience and Biotechnology from Drexel University.
He is a registered U.S.
Patent Attorney and maintains an active Pennsylvania law license.
At Enterprises, James focuses his time on identifying, analyzing and structuring investment opportunities that address unmet therapeutic need and align with UPMC’s vision of bringing life changing medicine to patients.
Aktive Positionen von James Bauersmith
Unternehmen | Position | Beginn |
---|---|---|
LANNETT COMPANY, INC. | Direktor/Vorstandsmitglied | - |
UPMC Enterprises
UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Corporate Officer/Principal | 01.08.2021 |
Ehemalige bekannte Positionen von James Bauersmith
Unternehmen | Position | Ende |
---|---|---|
ByHeart, Inc.
ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | General Counsel | 01.10.2021 |
AMNEAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 30.06.2019 |
FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 31.05.2018 |
AKORN, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von James Bauersmith
University of Notre Dame | Undergraduate Degree |
The Pennsylvania State University | Graduate Degree |
Drexel University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
LANNETT COMPANY, INC. | Health Technology |
AMNEAL PHARMACEUTICALS, INC. | Health Technology |
FRESENIUS SE & CO. KGAA | Health Technology |
Private Unternehmen | 3 |
---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
ByHeart, Inc.
ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Commercial Services |
UPMC Enterprises
UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |